For the two DLBCL primary cultures, cell viability was slightly decreased with a netrin-1 interfering monoclonal antibody, blocking netrin-1 binding to its dependence receptors, compared with controls (56% and 84% compared with 49% and 79%, respectively). This evidence concerns the gene NTN1 and diffuse large B-cell lymphoma.